Clinical Trial Update: Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 gene therapy trial for X-linked Chronic Granulomatous Disease in children has completed, sponsored by the University of Zurich. The document notes com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Gene therapy vector for X-linked Chronic Granulomatous Disease

Snippet

Sponsor: University of Zurich | Conditions: Chronic Granulomatous Disease | Phase 1, Phase 2 | Status: COMPLETED